Journal of Neurology

, Volume 260, Issue 2, pp 429–437 | Cite as

Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson’s disease

  • Juyeon Kim
  • Mijin Kim
  • Do Young Kwon
  • Woo-Keun Seo
  • Ji Hyun Kim
  • Jong Sam Baik
  • Seong-Beom Koh
Original Communication


Impulse control and repetitive behavior disorders (ICRBs) are a group of diseases including impulse control disorder (ICD), repetitive behavior disorder (RB), and dopamine dysregulation syndrome (DDS). This study determined the prevalence and associated characteristics of ICRBs in Parkinson’s disease (PD) patients. Included were 297 patients, interviewed with the questionnaire for impulsive-compulsive disorders in PD for screening of various ICRBs. Questionnaire results and clinical characteristics were analyzed. The ICRB prevalence among PD patients was 15.5 % (46 of 297), with 35 patients with ICD, 20 with RB, and 7 with DDS. Patients with ICRB were predominantly male, younger, taking higher doses of dopaminergic drugs, and had longer disease duration, worse Unified Parkinson’s Disease Rating Scale (UPDRS) motor score, and worse PD quality of life questionnaire score. However, each ICRB subtype had different risk factor profiles. ICD patients were predominantly male, younger, had longer disease duration, were affected by PD from young age, were taking higher total dopaminergic drug dosages, and had more RB. RB patients had higher UPDRS part III scores, were taking higher levodopa doses, and had higher comorbid ICD. DDS patients were taking higher dopamine agonist doses, and had more frequent ICD. In multivariate logistic regression for secondary analysis, only younger age and comorbid RB or DDS showed significant association with ICD and only poor UPDRS III score and comorbid ICD were significantly associated with RB. These findings suggested that different risk factors contribute to development of each ICRB subtype. ICRB could be a combination of heterogeneous disease entities that need to be treated separately.


Parkinson’s disease Impulse control disorder Repetitive behavior disorder Dopamine dysregulation syndrome 



We are grateful to Professor Daniel Weintraub for his permission of using the QUIP in this research. This study was supported by the basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2010-0027994).

Conflicts of interest


Ethical standard

This study has been approved by the appropriate ethics committee and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.


  1. 1.
    Hoehn MM (1992) The natural history of Parkinson’s disease in the pre-levodopa and post-levodopa eras. Neurol Clin 10:331–339PubMedGoogle Scholar
  2. 2.
    Damasio AR, Lobo-Antunes J, Macedo C (1971) Psychiatric aspects in Parkinsonism treated with l-dopa. J Neurol Neurosurg Psychiatry 34:502–507PubMedCrossRefGoogle Scholar
  3. 3.
    Evans AH, Lees AJ (2004) Dopamine dysregulation syndrome in Parkinson’s disease. Curr Opin Neurol 17:393–398PubMedCrossRefGoogle Scholar
  4. 4.
    Voon V, Fox SH (2007) Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 64:1089–1096PubMedCrossRefGoogle Scholar
  5. 5.
    Lim SY, Evans AH, Miyasaki JM (2008) Impulse control and related disorders in Parkinson’s disease: review. Ann N Y Acad Sci 1142:85–107PubMedCrossRefGoogle Scholar
  6. 6.
    Pontone G, Williams JR, Bassett SS, Marsh L (2006) Clinical features associated with impulse control disorders in Parkinson disease. Neurology 67:1258–1261PubMedCrossRefGoogle Scholar
  7. 7.
    Weintraub D, Koester J, Potenza MN et al (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589–595PubMedCrossRefGoogle Scholar
  8. 8.
    Voon V, Sohr M, Lang AE et al (2011) Impulse control disorders in Parkinson disease: a multicenter case–control study. Ann Neurol 69:986–996PubMedCrossRefGoogle Scholar
  9. 9.
    Weintraub D, Siderowf AD, Potenza MN et al (2006) Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 63:969–973PubMedCrossRefGoogle Scholar
  10. 10.
    Weintraub D, Hoops S, Shea JA et al (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease. Mov Disord 24:1461–1467PubMedCrossRefGoogle Scholar
  11. 11.
    Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRefGoogle Scholar
  12. 12.
    Herzog J, Volkmann J, Krack P et al (2003) Two-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease. Mov Disord 18:1332–1337PubMedCrossRefGoogle Scholar
  13. 13.
    Lee JY, Kim JM, Kim JW, Cho J, Lee WY, Kim HJ, Jeon BS (2010) Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord 16(3):202–207PubMedCrossRefGoogle Scholar
  14. 14.
    Goetz CG, Poewe W, Rascol O, Sampaio C (2005) Evidence-based medical review update: pharmacological and surgical treatments of Parkinson’s disease: 2001 to 2004. Mov Disord 20:523–539PubMedCrossRefGoogle Scholar
  15. 15.
    Voon V, Hassan K, Zurowski M et al (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67:1254–1257PubMedCrossRefGoogle Scholar
  16. 16.
    Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F (2006) Prevalence of pathological gambling in patients with Parkinson’s disease. Mov Disord 21:2068–2072PubMedCrossRefGoogle Scholar
  17. 17.
    Antonini A, Siri C, Santangelo G et al (2011) Impulsivity and compulsivity in drug naive patients with Parkinson’s disease. Mov Disord 26:464–468PubMedCrossRefGoogle Scholar
  18. 18.
    Christenson GA, Faber RJ, de Zwaan M et al (1994) Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 55:5–11PubMedGoogle Scholar
  19. 19.
    O’Sullivan SS, Djamshidian A, Ahmed Z et al (2010) Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy. Mov Disord 25:638–642PubMedCrossRefGoogle Scholar
  20. 20.
    Miyasaki JM, Al Hassan K, Lang AE, Voon V (2007) Punding prevalence in Parkinson’s disease. Mov Disord 22:1179–1181PubMedCrossRefGoogle Scholar
  21. 21.
    Evans AH, Katzenschlager R, Paviour D et al (2004) Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397–405PubMedCrossRefGoogle Scholar
  22. 22.
    Lawrence AJ, Blackwell AD, Barker RA et al (2007) Predictors of punding in Parkinson’s disease: results from a questionnaire survey. Mov Disord 22:2339–2345PubMedCrossRefGoogle Scholar
  23. 23.
    Wolters E, van der Werf YD, van den Heuvel OA (2008) Parkinson’s disease-related disorders in the impulsive-compulsive spectrum. J Neurol 255(Suppl 5):48–56PubMedCrossRefGoogle Scholar
  24. 24.
    Groenewegen HJ, Berendse HW, Wolters JG, Lohman AH (1990) The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: Evidence for a parallel organization. Prog Brain Res 85:95–116 (discussion 116–118)PubMedCrossRefGoogle Scholar
  25. 25.
    Pezzella FR, Colosimo C, Vanacore N et al (2005) Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson’s disease. Mov Disord 20:77–81PubMedCrossRefGoogle Scholar
  26. 26.
    Giovannoni G, O’Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostatic dysregulation in patients with Parkinson’s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423–428PubMedCrossRefGoogle Scholar
  27. 27.
    Lim SY, Tan ZK, Ngam PI et al (2011) Impulsive-compulsive behaviors are common in Asian Parkinson’s disease patients: assessment using the quip. Parkinsonism Relat Disord 17:761–764PubMedCrossRefGoogle Scholar
  28. 28.
    Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52–58PubMedCrossRefGoogle Scholar
  29. 29.
    Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162:1403–1413PubMedCrossRefGoogle Scholar
  30. 30.
    O’Sullivan SS, Evans AH, Lees AJ (2009) Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS drugs 23:157–170PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Juyeon Kim
    • 1
  • Mijin Kim
    • 1
  • Do Young Kwon
    • 1
  • Woo-Keun Seo
    • 1
  • Ji Hyun Kim
    • 1
  • Jong Sam Baik
    • 2
  • Seong-Beom Koh
    • 1
  1. 1.Department of NeurologyGuro Hospital, Korea University College of MedicineSeoulRepublic of Korea
  2. 2.Department of NeurologySanggye Paik Hospital, Inje University College of MedicineSeoulRepublic of Korea

Personalised recommendations